FDA approves Incyte’s Opzelura cream for children aged two and older with atopic dermatitis, expanding its use beyond teens and adults.
FDA Expands Incyte’s Opzelura Approval To Treat Atopic Dermatitis In Children
Where Today's News Shapes Tomorrow
